Veterinary

 

 

With the animal vaccines market predicted to be worth $8.6 billion by 2018, can you really afford not to be a core service provider for these manufacturers? An increased focus on zoonotic infectious diseases and more attention towards the economic impact of disease in livestock of economic importance, make it clear why veterinary vaccines are coming into the limelight. This event will provide a platform for you to showcase how you are moving veterinary vaccine development methods forward, from technology to regulation and manufacture.

 

 

Who Attends

 

• Pharma
• Biotech
• National and International Government
• Academics And Research Institutions

 

Job Titles

 

• CEO / CSO / COO
• CMO / Head of Scientific Affairs
• Head of Poultry / Avian / Bovine/ Swine/ Livestock
• Head of Infectious Disease
• Head of R&D
• Head of Manufacturing

Who Should Sponsor?

 

• CMOs
• OEMs / Equipment Manufacturers
• Platform Technology Providers
• Biotechs
• Big Pharma

 

Veterinary Vaccines Conference, Tuesday 16 April 2019

Cyril G Gay
Veterinary Vaccines Conference
09:00

Chair’s opening remarks

Dr Cyril Gay, Senior National Program Leader, Office of National Programs, USDA

Scientific Advancements in Animal Health

Simon Graham
Veterinary Vaccines Conference
09:10

Structural vaccinology and its potential impact on the next generation of veterinary vaccines

Dr Simon Graham, Group Leader, PRRS Immunology, The Pirbright Institute and Reader, University of Surrey
Mahesh Kumar
10:40

Networking Coffee Break

Thomas Monath
Veterinary Vaccines Conference
11:40

Animal viruses engineered as human vaccines against infections of animals transmissible to humans

Dr Tom Monath, Managing Partner and Chief Scientific Officer, Crozet BioPharma
Channing Sebo
Veterinary Vaccines Conference
12:10

Incorporating precision vaccines into swine health: The use of RNA tech Sequivity to develop custom vaccines targeting specific diseases in individual herds

Dr Channing Sebo, Technical Services Veterinarian, Merck Animal Health
Veterinary Vaccines Conference
12:40

Nanotechnology offers new vistas for the engineering of vaccine formulations

13:10

Networking Lunch & Poster Session

Precision Medicine Approaches for Animal Health

Tad Sonstegard
Veterinary Vaccines Conference
14:40

Precision breeding for animal health: How gene editing will improve our livestock systems

Dr Tad Sonstegard, CSO, Acceligen, Subsidiary of Recombinetics Inc.
Andy Hillier
Veterinary Vaccines Conference
15:10

Monoclonal antibodies for companion animal allergic skin diseases

Dr Andy Hillier, Medical Lead Dermatology and Allergy, Veterinary Specialty Operations, Zoetis Petcare
Peter Nara
Veterinary Vaccines Conference
15:40

Deceptive imprinting: A cosmopolitan host immune evading strategy of animal health pathogens

Dr Peter Nara, Chairman Emeritus, Biological Mimetics, Inc
16:09

Networking Coffee Break

Vaccine Delivery & Manufacture

Veterinary Vaccines Conference
16:40

Overcoming manufacturing challenges in the veterinary vaccine industry

Dr Dale Polson
Veterinary Vaccines Conference
17:10

Where is the future in veterinary vaccine delivery?

Dr Dale Polson, Lead, Integrated Health Systems, Boehringer Ingelheim Animal Health
Lisa Bielke
Veterinary Vaccines Conference
17:40

Orally administered vaccines for poultry

Dr Lisa R. Bielke, Assistant Professor, Department of Animal Sciences, The Ohio State University
18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, follow the congress team

last published: 23/Nov/18 12:35

Veterinary Vaccines Conference, Wednesday 17 April 2019

Cyril G Gay
Veterinary Vaccines Conference
09:00

Chair’s opening remarks

Dr Cyril Gay, Senior National Program Leader, A.R.S. National Programs, USDA

Alternatives to Antibiotics

Henk Haagsman
Veterinary Vaccines Conference
09:10

Overcoming the challenges of bacterial vaccine design

Dr Henk P. Haagsman, Professor of Molecular Host Defence, Chair of the Department ofInfectious Diseases & Immunology, Utrecht University
Veterinary Vaccines Conference
09:40

Incorporating microbiome therapeutics into animal health

Cindy Burnsteel
Veterinary Vaccines Conference
10:10

Regulatory pathways to enable the licensing of alternatives to antibiotics

Dr Cindy Burnsteel, Director, Division of Therapeutic Drugs for Food Animals, Centre for Veterinary Medicine, FDA
10:40

Networking Coffee Break

Emerging & Re-Emerging Diseases

Lisa Conti
Veterinary Vaccines Conference
11:30

Establishing a One Health approach to combat emerging zoonotic & transboundary diseases

Dr Lisa Conti, One Health Initiative & Deputy Commissioner and Chief Science Officer, Florida Department of Agriculture and Consumer Service
Jonna Mazet
Veterinary Vaccines Conference
11:45

PREDICT project: Detection and discovery of zoonotic diseases at the wildlife-human interface

Dr Jonna Mazet Professor of Epidemiology and Disease Ecology and Executive Director of the One Health Institute, UC Davis School of Veterinary Medicine & Global Director, PREDICT Project of USAID Emerging Pandemic Threats Program
Scott Holmstrom
Veterinary Vaccines Conference
12:00

New tools to combat Respiratory PRRS

Dr Scott Holmstrom, Senior Director, Global Product Development, Elanco Animal Health
Douglas Gladue
Veterinary Vaccines Conference
12:15

African Swine Fever – Still no vaccine, updates on how the animal health industry is targeting this disease?

Dr Doug Gladue, Senior Scientist, Plum Island Animal Disease Center, USDA
12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Gregory Poland
13:30

Chair's opening remarks

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic
Paul Offit
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 23/Nov/18 12:35

ONE HEALTH, Monday 15 April 2019

MORNING PLENARIES RENAISSANCE BALLROOM

Gregory Poland
08:20

Chair’s opening remarks

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic
Panel discussion
08:30

Opening plenary keynote insights: What direction will vaccines take to ensure safety and mass immunization?

  • What kind of regulatory and political support can we expect?
  • Prevention and pre-prepared efforts to ensure our current and future safety
  • Vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development
Panel discussion
10:20

Networking Coffee Break

INTERACTIVE ROUNDTABLES

11:20

Artificial intelligence -adopting cognitive computing across the PV landscape

11:20

Best practices for a Successful CRO/Pharma partnership for vaccine clinical studies

Marc Hoffman
11:20

Challenges for development of GMO vaccines

Marc Hoffman, Chief Medical Officer & Aernout van Haarst, Director Scientific Affairs, Celerion
11:20

Changing landscape of real-world evidence and its impact on clinical research – uncovering lab & clinical adverse events

Dr James Cummings
11:20

Developing more effective vaccines for emerging/re-emerging pandemic threats

Dr James F. Cummings, MD, President, ICON Government and Public Health Solutions – title TBC
11:20

Development of novel predictive algorithms for patient selection

11:20

Oncology – applying informatics to find the best treatment option for each patient

11:20

Overcoming obstacles to improve cold chain management of biologics

Dr Nathalie Garcon
11:20

Safety evaluation of vaccines: from now to tomorrow, new approaches and technologies?

Dr Nathalie Garcon, CSO & CEO, Bioaster
Cynthia Dukes
11:20

Seasonal vaccine studies: Critical success factors

Cynthia Dukes, VP, Scientific and Clinical Services and Head of Vaccine Center of Excellence, ICON Clinical Research – title TBC
Jason Berg
11:20

The use of ePRO solutions and platforms in vaccine studies

Jason Berg, Director of Project Management, PPD – title TBC
Jason Berg, Director, Project Management, PPD
Dr Jun Tang
11:20

When limited patient resources meet unlimited immunotherapy combinations—the strategies to develop clinical IO agents in platform studies

12:40

Networking Lunch (Exhibition Hall)

AFTERNOON PLENARIES

Rino Rappuoli
14:10

The role of vaccines to combat antibiotic-microbial resistance

  • What can we do to manage AMR? The mis-use of Abx in bacterial and viral infections
  • How vaccine regulatory and access policies can be used to strengthen utilization of vaccines as a component of multi-pronged strategies that governments should take in their national action plans to address AMR
  • The need for a holistic and collaborative strategy including cross species considerations
Panel discussion
15:00

Fire chat: The future of the vaccine business from the executives

  • What vaccines will they invest in and why
  • How will we translate data heavy tools into translational precision medicines?
  • Can we continue to be dependent on industry for process development and advanced clinical development, especially for products destined for LMICs?
  • Should it be industry’s responsibility to help address vaccine hesitancy?
Johan Van Hoof, Global Therapeutic Area Head of Infectious Diseases and Vaccines and Managing Director, Johnson and Johnson
16:00

Networking Coffee Break

ONE HEALTH

Panel discussion
ONE HEALTH
16:40

One Health pharma strategy update

  • Examining the strategic context, rationale and case for investing in One Health
  • How are the veterinary pharma companies working towards a implementing a One Health approach?
Panel discussion
ONE HEALTH
17:40

Operational framework for strengthening human & animal public health systems at their interface

  • What tools and resources from the human health, animal health, and disaster risk reduction sectors can facilitate multi-sectoral coordination?
  • Strategy for appropriate One Health entry points and a pathway to the prevent-detect-respond-recover spectrum of preparedness
  • What public health system changes do we need to truly facilitate a One Health approach?
18:40

Chair’s Closing Remarks and Close of Congress Day 1

18:50

Pre-Awards Networking Drinks Reception (off-site)

19:30

Gala Dinner & 12th Annual ViE Awards Ceremony

last published: 23/Nov/18 12:35

 

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071